738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trialMaria Pouyiourou, A. Krämer, Bianca Kraft et al.|Annals of Oncology|2022Cited by 3
Nal-Iri and 5-FU/LV Compared to 5-FU/LV in Patients with Cholangio- and Gallbladder Carcinoma Previously Treated with Gemcitabine-Based Therapies: The AIO NALIRICC TrialArndt Vogel, Martha M. Kirstein, Gunnar Folprecht et al.|SSRN Electronic Journal|2024Cited by 0